NASDAQ:ACRS
Aclaris Therapeutics Stock News
$1.26
+0.0500 (+4.13%)
At Close: May 01, 2024
Xbox One S vs. Xbox One X: Which should you buy?
10:00am, Thursday, 28'th May 2020
When it comes to Xbox, right now you have two different consoles to choose from. Which is better for you? Let's take a look.
Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference
08:01pm, Tuesday, 26'th May 2020
WAYNE, Pa., May 26, 2020 -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that.
Charity manager gets on her bike for domestic abuse victims - The Wokingham Paper
05:00am, Saturday, 16'th May 2020
HEAVILY involved in the world of charities and fundraising, a woman is tackling a 26 marathon challenge in aid of domestic abuse victims.
Now, give personal details while buying cold, cough and fever drugs
05:11pm, Friday, 15'th May 2020
The details of such customers has to be uploaded on the portal developed by the Food Safety and Drug Administration (FSDA) by the retail chemists in the state.
Will Aclaris Therapeutics Continue to Surge Higher?
02:47pm, Tuesday, 12'th May 2020
As of late, it has definitely been a great time to be an investor Aclaris Therapeutics
All You Need to Know About Aclaris (ACRS) Rating Upgrade to Buy
04:00pm, Friday, 08'th May 2020
Aclaris (ACRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Aclaris Therapeutics Reports First Quarter 2020 Financial Results and Provides R&D and Business Highlights
08:01pm, Thursday, 07'th May 2020
Projected Cash Runway into the First Quarter of 2022Borrowed $11 Million from Term Loan Facility WAYNE, Pa., May 07, 2020 -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a.
Aclaris Therapeutics (ACRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04:30pm, Wednesday, 06'th May 2020
Aclaris (ACRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bank of New York Mellon Corp Acquires 95,527 Shares of Aclaris Therapeutics Inc (NASDAQ:ACRS)
10:04am, Thursday, 30'th Apr 2020
Bank of New York Mellon Corp boosted its position in Aclaris Therapeutics Inc (NASDAQ:ACRS) by 76.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange
Aclaris Therapeutics (NASDAQ:ACRS) Downgraded by Zacks Investment Research to "Hold"
09:30am, Thursday, 16'th Apr 2020
Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, �
Does The Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Share Price Fall With The Market?
10:13am, Thursday, 09'th Apr 2020
Anyone researching Aclaris Therapeutics, Inc. (NASDAQ:ACRS) might want to consider the historical volatility of the...
Man Group plc Sells 2,438,827 Shares of Aclaris Therapeutics Inc (NASDAQ:ACRS)
12:38pm, Wednesday, 08'th Apr 2020
Man Group plc reduced its holdings in shares of Aclaris Therapeutics Inc (NASDAQ:ACRS) by 65.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,295,966 shares
Aclaris Therapeutics (NASDAQ:ACRS) Upgraded by Zacks Investment Research to "Buy"
10:37am, Tuesday, 07'th Apr 2020
Zacks Investment Research upgraded shares of Aclaris Therapeutics (NASDAQ:ACRS) from a hold rating to a buy rating in a report released on Monday morning, Zacks.com reports. The brokerage currently ha
Aclaris (ACRS) Upgraded to Buy: Here's Why
04:00pm, Monday, 06'th Apr 2020
Aclaris (ACRS) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wayne biopharma firm borrows $11M to fund new business strategy
03:07pm, Wednesday, 01'st Apr 2020
The funds will extend the 'cash runway' for a company that six months ago shifted its product development focus.
